OpGen, Inc. (OPGN)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 6, 2025, 5:14 PM EDT
OpGen Market Cap
OpGen has a market cap or net worth of $1.01 thousand as of October 7, 2025. Its market cap has decreased by -99.97% in one year.
Market Cap
1.01K
Enterprise Value
869.66K
Revenue
5.03M
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
Market Cap Chart
Since May 5, 2015, OpGen's market cap has decreased from 51.90M to 1.01K, a decrease of -100.00%. That is a compound annual growth rate of -64.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 1.01K | -99.98% |
| Dec 31, 2024 | 5.99M | 42.44% |
| Dec 29, 2023 | 4.21M | -44.45% |
| Dec 30, 2022 | 7.57M | -80.56% |
| Dec 31, 2021 | 38.95M | -15.10% |
| Dec 31, 2020 | 45.88M | 1,069.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |